Wednesday, May 22, 2013 Last update: 7:37 AM
Company Tech News as it Breaks
Trade Events
Infinity Pharmaceuticals, Inc.
News articles for Infinity Pharmaceuticals, Inc.:
Wednesday, May 22, 2013
- Infinity to Present at Deutsche Bank's 38th Annual Health Care ConferenceInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at Deutsche Bank's 38th Annual Health Care Conference on May 29, 2013, at 4:15 p.m. ET in Boston, MA. ... read more
Wednesday, May 15, 2013
- Infinity Announces Clinical Data to Be Presented at ASCO and ICMLInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Phase 1 clinical data for IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented ... read more
Tuesday, May 14, 2013
- Infinity to Present at the UBS Global Healthcare ConferenceInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the UBS Global Healthcare Conference on May 21, 2013, at 12:30 p.m. ET in New York. ... read more
Tuesday, May 7, 2013
- Infinity Reports First Quarter 2013 Financial Results and Provides Company UpdateInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported its first quarter 2013 financial results and ongoing progress with IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, ... read more
Wednesday, April 24, 2013
- Infinity Announces the Date of Its First Quarter 2013 Financial Results Conference Call and WebcastInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 7, 2013, at 4:30 p.m. ET. During the call, management will provide an update on ... read more
Tuesday, April 9, 2013
- Infinity Announces Proposed Secondary Offering of Common StockInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced an underwritten public offering of its common stock by existing stockholders Beacon Company and Rosebay Medical Company L.P., including ... read more
Tuesday, March 5, 2013
- Infinity Provides Company Update and Reports Full-Year 2012 Financial ResultsInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported its full-year 2012 financial results and ongoing progress with IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, ... read more
Tuesday, February 19, 2013
- Infinity Announces the Date of Its Full-Year 2012 Financial Results Conference Call and WebcastInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, March 5, 2013, at 4:30 p.m. ET. During the call, management will provide an update on ... read more
Wednesday, February 6, 2013
- Infinity to Participate in Three Conferences in FebruaryInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following conferences in February 2013: ... read more
Monday, December 31, 2012
- Infinity to Present at the J.P. Morgan Annual Healthcare ConferenceInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the J.P. Morgan 31st Annual Healthcare Conference on January 7, 2013, at 10:00 a.m. ET in San Francisco, CA. ... read more
Monday, December 24, 2012
- Infinity Amends PI3K-Delta,Gamma Agreement with MillenniumInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company amended its development and license agreement with Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Company Limited ... read more
Tuesday, December 18, 2012
- Infinity Announces Closing of Public Offering and Exercise of Over-Allotment OptionInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the closing of its previously announced underwritten registered public offering of common stock. The total number of shares of common stock ... read more
Thursday, December 13, 2012
- Infinity Prices Public Offering of Common StockInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the pricing of an underwritten registered public offering of 5,696,923 shares of its common stock at a public offering price of ... read more
Wednesday, December 12, 2012
- Infinity Announces Proposed Public Offering of Common StockInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering ... read more
Monday, December 10, 2012
- Infinity Reports IPI-145 Phase 1 Data Showing Clinical Activity in B-Cell and T-Cell Malignancies at ASH Annual MeetingInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company’s potent, oral inhibitor of phosphoinositide-3-kinase ... read more
Monday, November 26, 2012
- Infinity to Present at Deutsche Bank Securities’ 2012 dbAccess BiofestInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2012 dbAccess Biofest on December 3, 2012 at 1:40 p.m. ET in Boston. ... read more